Abiopharma

New Form 8-K - ArriVent BioPharma, Inc. Filed: 2025-07-02 AccNo: 0001104659-25-065386 Size: 738 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits